BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND Ki-67 AND Clinical Outcome
73 results:

  • 1. Well-differentiated gastro-entero-pancreatic neuroendocrine tumors with positive FDG-PET/CT: a retrospective chart review.
    Haidar M; Al Mahmasani L; Chehade L; Elias C; El Jebai M; Temraz S; Charafeddine M; Al Darazi M; Shamseddine A
    Nucl Med Commun; 2023 Jun; 44(6):471-479. PubMed ID: 36897058
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. TOP2A Expression in Pheochromocytoma and Abdominal Paraganglioma: a Marker of Poor clinical outcome?
    Solhusløkk Höse K; Stenman A; Svahn F; Larsson C; Juhlin CC
    Endocr Pathol; 2023 Mar; 34(1):129-141. PubMed ID: 36656469
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Typical and Atypical Carcinoid tumors of the Mediastinum: A Biomarker Analysis of 27 Cases With clinical Correlation.
    Zaleski M; Kalhor N; Moran CA
    Int J Surg Pathol; 2021 Jun; 29(4):358-367. PubMed ID: 33243039
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large cell Neuroendocrine Carcinomas with Distinct Prognosis.
    Milione M; Maisonneuve P; Grillo F; Mangogna A; Centonze G; Prinzi N; Pusceddu S; Garzone G; Cattaneo L; Busico A; Bossi P; Spaggiari P; Pellegrinelli A; Del Gobbo A; Ferrero S; Kankava K; Pruneri G; Rolli L; Roca E; Bercich L; Tironi A; Benvenuti MR; Gallazzi MS; Romano R; Berruti A; Pastorino U; Capella C
    Neuroendocrinology; 2021; 111(5):475-489. PubMed ID: 32365350
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Role of Histologic Grading and ki-67 Index in Predicting outcomes in Pulmonary Carcinoid tumors.
    Dermawan JKT; Farver CF
    Am J Surg Pathol; 2020 Feb; 44(2):224-231. PubMed ID: 31490236
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Effects of low-dose aspirin on clinical outcome and disease progression in patients with gastroenteropancreatic neuroendocrine neoplasm.
    Cavalcoli F; Pusceddu S; Zilli A; Tamagno G; Femia D; Prinzi N; Travers J; Consonni D; Ciafardini C; Conte D; Massironi S
    Scand J Gastroenterol; 2019 Sep; 54(9):1111-1117. PubMed ID: 31454281
    [No Abstract]    [Full Text] [Related]  

  • 7. SEL1L plays a major role in human malignant gliomas.
    Mellai M; Annovazzi L; Boldorini R; Bertero L; Cassoni P; De Blasio P; Biunno I; Schiffer D
    J Pathol Clin Res; 2020 Jan; 6(1):17-29. PubMed ID: 31111685
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab.
    Manneh Kopp RA; Sepúlveda-Sánchez JM; Ruano Y; Toldos O; Pérez Núñez A; Cantero D; Hilario A; Ramos A; de Velasco G; Sánchez-Gómez P; Hernández-Laín A
    Clin Transl Oncol; 2019 Oct; 21(10):1413-1423. PubMed ID: 30877636
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Somatic aberrations of BRCA1 gene are associated with ALDH1, EGFR, and tumor progression in prostate cancer.
    Omari A; Nastały P; Stoupiec S; Bałabas A; Dąbrowska M; Bielińska B; Huss S; Pantel K; Semjonow A; Eltze E; Brandt B; Bednarz-Knoll N
    Int J Cancer; 2019 Feb; 144(3):607-614. PubMed ID: 30265376
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients.
    Zhang J; Kulkarni HR; Singh A; Niepsch K; Müller D; Baum RP
    J Nucl Med; 2019 Mar; 60(3):377-385. PubMed ID: 30115686
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Immunohistochemical CD271 expression correlates with melanoma progress in a case-control study.
    Nielsen PS; Riber-Hansen R; Steiniche T
    Pathology; 2018 Jun; 50(4):402-410. PubMed ID: 29678478
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Composite Pheochromocytoma/Paraganglioma-Ganglioneuroma: A Clinicopathologic Study of Eight Cases with Analysis of Succinate Dehydrogenase.
    Gupta S; Zhang J; Erickson LA
    Endocr Pathol; 2017 Sep; 28(3):269-275. PubMed ID: 28752484
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Stemness Marker Detection in the Periphery of Glioblastoma and Ability of Glioblastoma to Generate Glioma Stem cells: clinical Correlations.
    Raysi Dehcordi S; Ricci A; Di Vitantonio H; De Paulis D; Luzzi S; Palumbo P; Cinque B; Tempesta D; Coletti G; Cipolloni G; Cifone MG; Galzio R
    World Neurosurg; 2017 Sep; 105():895-905. PubMed ID: 28559081
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome.
    Klieser E; Urbas R; Stättner S; Primavesi F; Jäger T; Dinnewitzer A; Mayr C; Kiesslich T; Holzmann K; Di Fazio P; Neureiter D; Swierczynski S
    Hum Pathol; 2017 Jul; 65():41-52. PubMed ID: 28235630
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future.
    Ohmoto A; Rokutan H; Yachida S
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098761
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Anaplastic lymphoma kinase expression and gene alterations in glioblastoma: correlations with clinical outcome.
    Karagkounis G; Stranjalis G; Argyrakos T; Pantelaion V; Mastoris K; Rontogianni D; Komaitis S; Kalamatianos T; Sakas D; Tiniakos D
    J Clin Pathol; 2017 Jul; 70(7):593-599. PubMed ID: 27993946
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Neuroendocrine neoplasms of liver - A 5-year retrospective clinico-pathological study applying World Health Organization 2010 classification.
    Burad DK; Kodiatte TA; Rajeeb SM; Goel A; Eapen CE; Ramakrishna B
    World J Gastroenterol; 2016 Oct; 22(40):8956-8966. PubMed ID: 27833387
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [A case of urothelial carcinoma with trophoblastic differentiation and review of the literature].
    Cazorla A; Sibony M; Pedron P; Munz-Beaugrand C
    Ann Pathol; 2016 Oct; 36(5):347-350. PubMed ID: 27639773
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. IDH1/2 mutation status combined with ki-67 labeling index defines distinct prognostic groups in glioma.
    Zeng A; Hu Q; Liu Y; Wang Z; Cui X; Li R; Yan W; You Y
    Oncotarget; 2015 Oct; 6(30):30232-8. PubMed ID: 26338964
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.
    Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH
    J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.